COO — Cooper Companies Cashflow Statement
0.000.00%
HealthcareBalancedLarge CapHigh Flyer
- $17.56bn
- $20.14bn
- $3.31bn
- 90
- 17
- 97
- 77
Annual cashflow statement for Cooper Companies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 140 | 467 | 238 | 2,945 | 386 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 131 | 21.7 | 87.8 | 137 | 80.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 120 | -40.1 | -126 | -150 | -174 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 669 | 713 | 487 | 739 | 692 |
Capital Expenditures | -194 | -292 | -310 | -214 | -242 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1,324 | -59.2 | -54.1 | -236 | -1,589 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,518 | -351 | -365 | -450 | -1,831 |
Financing Cash Flow Items | -2.3 | 7.4 | -10.3 | 20.4 | -10.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 844 | -351 | -95.5 | -311 | 1,194 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.6 | 9.3 | 27.3 | -20.2 | 42 |